U.S. claims that dozens of Russian diplomats and their spouses cheated to get health care aid...
The Food and Drug Administration said Wednesday that it reached a $1.25 million settlement with...
JHL Biotech, Inc., a provider of biopharmaceutical process development and manufacturing...
Zogenix, Inc. and Battelle have entered into a new long-term collaborative agreement regarding co-marketing of Zogenix's DosePro(R) needle-free drug delivery technology, advancing potential out-licensing opportunities for DosePro with biopharmaceutical clients, and expanding the application of the technology to higher-dose biologic therapies.
A traveling medical technician who stole painkillers and infected dozens of patients in multiple states with hepatitis C through tainted syringes was sentenced Monday to 39 years in prison. Kwiatkowski, 34, was a cardiac technologist in 18 hospitals in seven states before being hired at New Hampshire's Exeter Hospital in 2011.
The co-owner of a now-defunct Virginia drug company has pleaded guilty to illegally importing Botox and other prescription drugs and selling them to physicians in violation of the Food and Drug Administration's regulatory scheme.
A traveling medical technician who infected dozens of patients in multiple states with hepatitis C through tainted syringes is due to find out today how many decades he'll spend in a New Hampshire prison. Kwiatkowski, who has admitted stealing painkillers and replacing them with saline-filled syringes tainted with his blood, pleaded guilty in August to 16 federal drug charges.
A class action suit by Australian and New Zealand victims of Thalidomide against the anti-morning sickness drug's British distributor Diageo Scotland Ltd. has been settled for 89 million Australian dollars ($81 million), a lawyer said on Monday.
Authorities in Michigan and Massachusetts say they will coordinate their investigations of a company that sold steroid injection materials linked to a fungal meningitis outbreak that sickened hundreds of people in 20 states.
The Food and Drug Administration has ordered Google-backed genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is supported by science.
Dirk Thompson doesn't hold out much hope that he and the 750 other victims in a nationwide meningitis outbreak will ever see much, if any, compensation for the deaths and illnesses caused by tainted steroids. He hopes to find justice another way if criminal charges are brought against the principals of a Massachusetts compounding pharmacy that made the steroid injections blamed for the fungal meningitis outbreak.
Twenty-five pharmaceutical companies will pay the state $88 million to resolve allegations they charged Louisiana's Medicaid program too much for their drugs, the final settlement reached in a 2010 lawsuit filed by Attorney General Buddy Caldwell.
Vertex Pharmaceuticals Inc. is selling its product royalty rights for the hepatitis C treatment Incivo for $152 million to Johnson & Johnson subsidiary Janssen Pharmaceutica. Vertex said Wednesday that Janssen will make the cash payment in the fourth quarter and then stop paying royalties in...
The proposed legislation is part of a set of new proposals, outlined Tuesday, that are meant to address problems revealed by a series of catastrophic failures at the Stafford Hospital in central England, when hundreds of patients died unnecessarily from 2005 to 2009.
A Spanish court has ordered a German pharmaceutical company to pay compensation to 22 Spaniards born with disabilities after their mothers used the drug thalidomide during pregnancy decades ago.
Johnson & Johnson said late Tuesday that it will pay $2.5 billion to settle thousands of lawsuits brought by hip replacement patients who accuse the company of selling faulty implants that led to injuries and additional surgeries.
Israel's Teva Pharmaceuticals Industries Ltd. says it has reached an agreement with the country's tax authority to pay roughly $718 million to settle a series of claims against the drug maker. The money will settle tax assessments on "trapped profits," earnings that result from special corporate tax breaks, and pay separate back taxes.
A troubled dietary supplement maker in Virginia will start next year off with a new leader after its chief executive announced his resignation, a shakeup that comes as the company faced a securities probe, shareholder lawsuits and a scandal involving Virginia's governor.
Two sales representatives from a Virginia pharmaceutical company have pleaded guilty to their roles in a scheme to illegally import millions of dollars' worth in prescription drugs into the U.S.
The state attorney general's office announced the settlement Tuesday with McKesson Corp. The settlement also includes another $277,000 from First DataBank Inc. for its alleged role in fraud.
Ohio's Medicaid program will receive $52.7 million through a national settlement with a pharmaceutical company. The $2.2 billion settlement announced Monday involves Johnson & Johnson, one of its subsidiaries, the federal government and several states.
Johnson & Johnson has agreed to pay over $2.2 billion to resolve criminal and civil allegations that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients, the Department of Justice announced on Monday.
The Food and Drug Administration announced a new proposal Thursday to try and head off more shortages of crucial medications that have disrupted care at hospitals and clinics nationwide. Under the proposed rule, companies that make medically important prescription medicines would have to notify the FDA six months ahead of any changes that could disrupt the U.S. supply.
The FDA asked Ariad to stop marketing the drug, but the company is negotiating with the FDA about changes to prescribing information and new ways to manage the risks associated with Iclusig. Ariad said it wants to resume marketing the drug. The daily pill is Ariad's only approved product.
Valeant Pharmaceuticals will pay Anacor Pharmaceuticals $142.5 million in a settlement, the companies said Monday. The payment will be made by Nov. 8, and it will resolve all disputes between Anacor and Valeant. That includes legal proceedings involving Medicis Pharma, which Valeant acquired in...
Shares of Anacor Pharmaceuticals climbed Friday after the company said an arbitrator is awarding the company $100 million in a dispute with Canadian drugmaker Valeant Pharmaceuticals. The companies said Valeant was ordered to pay $100 million in damages and will also have to pay costs and...
Two Colorado farmers whose cantaloupes were tainted with listeria have filed a lawsuit blaming a food-safety auditor that didn't pick up safety problems and gave the farm a "superior" rating just a month before the nation's deadliest case of foodborne illness in a quarter century.
John Lazorchak, a former director of financial reporting at Summit-based Celgene Corp., and Mark Cupo, who held a similar position at Sanofi-Aventis, a France-based company with U.S. headquarters in Bridgewater, each pleaded guilty in federal court Monday to five counts of securities fraud.
- Page 1